⌘K

Login Start Free

Home/Filings/4/0000059478-25-000026

4//SEC Filing

Ricks David A 4

Accession 0000059478-25-000026

CIK 0000059478other

View on SEC.gov Company Profile

Filed

Feb 3, 7:00 PM ET

Accepted

Feb 4, 4:24 PM ET

Size

11.2 KB

Accession

0000059478-25-000026

Insider Transaction Report

Form 4

Period: 2025-02-01

ELI LILLY & CoLLY

SVP and Pres, Lilly Bio-Meds

Transactions

Tax Payment
Common Stock
2025-02-01$811.08/sh−11,903.393$9,654,604→ 484,481.607 total
Exercise/Conversion
Restricted Stock Unit
2025-02-01−26,561→ 0 total
From: 2025-02-01Exp: 2025-02-01→ Common Stock (26,561 underlying)
Exercise/Conversion
Common Stock
2025-02-01+26,561→ 496,385 total

Holdings

Common Stock
(indirect: By David A. Ricks SLAT)
68,656
Common Stock
(indirect: By 401(k))
7,264.97
Common Stock
(indirect: By David A. Ricks 2022 GRAT)
59,457
Common Stock
(indirect: By Trust)
300

Footnotes (2)

[F1]The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
[F2]Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.

Documents

1 file

4
wk-form4_1738704275.xmlPrimary
FORM 4

Issuer

ELI LILLY & Co

CIK 0000059478

Entity typeother

Related Parties

1

filerCIK 0001538604

Filing Metadata

Form type: 4
Filed: Feb 3, 7:00 PM ET
Accepted: Feb 4, 4:24 PM ET
Size: 11.2 KB

View on SEC.gov